A single dose of intravenous dexamethasone, when added to standard treatment of a migraine attack, is associated with a 26% decrease in headache recurrence in the following 72 hours.
Samo jedna doza intravenski primijenjenog deksametazona, uz uobičajeno liječenje napada migrene, povezana je s 26%-tnim smanjenjem recidiva u narednih 72 sata.